New Insights into the Role of Podoplanin in Epithelial-Mesenchymal Transition

被引:51
|
作者
Renart, Jaime [1 ]
Carrasco-Ramirez, Patricia [1 ]
Fernandez-Munoz, Beatriz [2 ]
Martin-Villar, Ester [1 ]
Montero, Lucia [1 ]
Yurrita, Maria M. [1 ]
Quintanilla, Miguel [1 ]
机构
[1] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain
[2] Lab Andaluz Reprogramac Celular, Seville, Spain
关键词
SQUAMOUS-CELL CARCINOMA; CANCER-ASSOCIATED FIBROBLASTS; AGGREGATION-INDUCING FACTOR; PREDICTS POOR-PROGNOSIS; LECTIN RECEPTOR CLEC-2; CENTRAL-NERVOUS-SYSTEM; LYMPHATIC ENDOTHELIAL-CELLS; PROMOTES TUMOR PROGRESSION; TRANSCRIPTION FACTOR SNAIL; MUCIN-TYPE GLYCOPROTEIN;
D O I
10.1016/bs.ircmb.2015.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Podoplanin is a small mucin-like transmembrane protein expressed in several adult tissues and with an important role during embryogenesis. It is needed for the proper development of kidneys and lungs as well as accurate formation of the lymphatic vascular system. In addition, it is involved in the physiology of the immune system. A wide variety of tumors express podoplanin, both in the malignant cells and in the stroma. Although there are exceptions, the presence of podoplanin results in poor prognosis. The main consequence of forced podoplanin expression in established and tumor-derived cell lines is an increase in cell migration and, eventually, the triggering of an epithelial mesenchymal transition, whereby cells acquire a fibroblastoid phenotype and increased motility. We will examine the current status of the role of podoplanin in the induction of epithelial-mesenchymal transition as well as the different interactions that lead to this program.
引用
收藏
页码:185 / 239
页数:55
相关论文
共 50 条
  • [41] Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
    Ge, Xiaoyong
    Yao, Yuan
    Li, Jing
    Li, Zhaonan
    Han, Xinwei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition
    Feng, Jing
    Hu, Shaofan
    Liu, Keli
    Sun, Guiyin
    Zhang, Yiguo
    CELLS, 2022, 11 (13)
  • [43] Role of epithelial-mesenchymal transition in tumor progression DISCUSSION
    Pessac, M. Bernard
    Tubiana, M. Maurice
    Rouesse, M. Jacques
    Dreux, M. Claude
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2009, 193 (09): : 2032 - 2034
  • [44] The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition
    Fernandez-Munoz, Beatriz
    Yurrita, Maria M.
    Martin-Villar, Ester
    Carrasco-Ramirez, Patricia
    Megias, Diego
    Renart, Jaime
    Quintanilla, Miguel
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (06): : 886 - 896
  • [45] Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton
    Wicki, A
    Lehembre, F
    Wick, N
    Hantusch, B
    Kerjaschki, D
    Christofori, G
    CANCER CELL, 2006, 9 (04) : 261 - 272
  • [46] Transcriptional controls for epithelial-mesenchymal and mesenchymal epithelial transition
    Hay, ED
    FASEB JOURNAL, 2004, 18 (05): : A762 - A762
  • [47] Epithelial-mesenchymal transition in cancer
    Moustakas, Aristidis
    Garcia de Herreros, Antonio
    MOLECULAR ONCOLOGY, 2017, 11 (07): : 715 - 717
  • [48] A milestone in epithelial-mesenchymal transition
    Sun, Yutong
    Ma, Li
    NATURE CELL BIOLOGY, 2024, 26 (01) : 29 - 30
  • [49] Epithelial-mesenchymal transition in the skin
    Nakamura, Motonobu
    Tokura, Yoshiki
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 61 (01) : 7 - 13
  • [50] Targeting epithelial-mesenchymal transition
    Luft, Friedrich C.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (07): : 703 - 705